SFMBT2 and prostate carcinoma: We previously reported that down-regulation of SFMBT2 promotes prostate cancer metastasis through the up-regulation of MMPs and that expression level of SFMBT2 inversely correlates with the prognosis of prostate cancer patients such as invasion and metastasis [26].